Pharmanutra S.p.A. (BIT:PHN)
81.90
-0.10 (-0.12%)
Jul 28, 2026, 9:53 AM CET
Pharmanutra Revenue
Pharmanutra had revenue of 33.40M EUR in the quarter ending March 31, 2026, with 24.51% growth. This brings the company's revenue in the last twelve months to 102.25M, up 17.16% year-over-year. In the year 2025, Pharmanutra had annual revenue of 136.25M with 15.15% growth.
Revenue (ttm)
102.25M
Revenue Growth
+17.16%
P/S Ratio
5.65
Revenue / Employee
992.43K
Employees
140
Market Cap
785.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 136.25M | 17.93M | 15.15% |
| Dec 31, 2024 | 118.32M | 16.36M | 16.05% |
| Dec 31, 2023 | 101.96M | 18.57M | 22.27% |
| Dec 31, 2022 | 83.39M | 14.56M | 21.15% |
| Dec 31, 2021 | 68.84M | 10.16M | 17.31% |
| Dec 31, 2020 | 58.68M | 4.47M | 8.24% |
| Dec 31, 2019 | 54.21M | 6.09M | 12.66% |
| Dec 31, 2018 | 48.12M | 10.33M | 27.33% |
| Dec 31, 2017 | 37.79M | 4.97M | 15.12% |
| Dec 31, 2016 | 32.83M | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| Safilo Group | 983.38M |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Philogen | 319.73M |
Pharmanutra News
- 2 months ago - Pharmanutra Earnings release: Q1 2026 - Filings
- 2 months ago - Pharmanutra Slides: Q1 2026 - Filings
- 2 months ago - Pharmanutra Quarterly report: Q1 2026 - Filings